Results 151 to 160 of about 12,312 (182)

Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG

Cancer Cell, 2019
Philip Cole, Sanda Alexandrescu, Yang Shi   +2 more
exaly  

LSD1 sustains pancreatic cancer growth via maintaining HIF1α-dependent glycolytic process

Cancer Letters, 2014
Tianjiao Li, Chen Liu, Xianjun Yu
exaly  

Cyclopropylamines as LSD1 inhibitors

2015
WU LIANGXING, HE CHUNHONG, QIAN DING-QUAN, SHEN BO, YAO WENQING   +4 more
openaire   +17 more sources

LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade

Cell, 2018
Pang-Hung Hsu, Yang Shi, Eliezer Van Allen   +2 more
exaly  

Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors

European Journal of Medicinal Chemistry, 2020
Dongmei Zhao, Xiangyu Zhang, MAOSHENG Cheng   +2 more
exaly  

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

2012
JOHNSON NEIL W, KASPAREC JIRI, MILLER WILLIAM HENRY, ROUSE MEAGAN B, SUAREZ DOMINIC, TIAN XINRONG   +5 more
openaire   +4 more sources

Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1/KDM1A inhibitors

European Journal of Medicinal Chemistry, 2019
Hong-Min Liu, Bin Yu, Bin Yu
exaly  

FORMULATIONS OF AN LSD1 INHIBITOR

2017
ROCCO WILLIAM L, LIU YING, LI MEI, SHAH TANVI, WU HUIFANG   +4 more
openaire   +3 more sources

Phosphorylation of LSD1 at Ser112 is crucial for its function in induction of EMT and metastasis in breast cancer

Breast Cancer Research and Treatment, 2016
Guannan Wang, Baiqu Huang, Yu Zhang
exaly  

Experience-based discovery (EBD) of aryl hydrazines as new scaffolds for the development of LSD1/KDM1A inhibitors

European Journal of Medicinal Chemistry, 2019
Hong-Min Liu, Bin Yu, Bin Yu
exaly